Search | Page 21 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for January 2015

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 12/30/2014 - 10:45am.

  2. Clinical Trials Report for March 2015

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of this ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 03/02/2015 - 10:06am.

  3. Biting into the Elephant

    ... hope in my physician. We formulated our plan which was azacitidine (Vidaza®) treatment followed by a stem cell transplant ...

    Patient Chronicle last updated 06/27/2016 - 2:22pm.

  4. Clinical Trials Report for December 2014

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 11/25/2014 - 3:33pm.

  5. Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes

    ... Associated Drug(s):  Azacitidine Phase:  ... Intervention:  Drug: CC-486 (ORAL AZACITIDINE) 200 mg CC-486 (Oral Azacitidine) will be given for the first 21 ...

    Clinical Trial last updated 04/19/2016 - 12:22pm.

  6. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... Associated Drug(s):  Azacitidine Phase:  ... dose (MTD) from Phase I. Other Names: Azacitidine 5-aza Vidaza 5-AZC AZA-CR ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  7. Research Retrospective for AA&MDSIF 30th Anniversary - Dr. Mikkael Sekeres

    ... 2009 demonstrated that for the first time, an MDS drug, azacitidine , has provided a survival advantage. We have a rising number ...

    Interview last updated 05/08/2013 - 2:51pm.

  8. Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant (ICT-HCT)

    ... Associated Drug(s):  Azacitidine Decitabine ... Intervention:  Drug: Azacitidine Given IV or SC Other Names: 5 ...

    Clinical Trial last updated 04/27/2016 - 9:41am.

  9. Evaluation of RUX and AZA Combination as a Therapy For Patients With Myelofibrosis And Myelodysplastic Syndrome/ Myeloproliferative Neoplasm

    ... Associated Drug(s):  Azacitidine Phase:  ... 1, 2 and 3. Other Names: Jakafi INCB018424 INC424 Drug: Azacitidine (AZA) Four weeks (28 days) on therapy is considered one standard ...

    Clinical Trial last updated 04/28/2016 - 1:56pm.

  10. Dr. Matt Walter on Mentorship

    ... MDS patients with a combination of drugs, vosaroxin and azacitidine .  Vosaroxin has a different mechanism of action than azacitidine. It can cause DNA damage to MDS cells. We will determine whether a ...

    Interview last updated 07/20/2015 - 1:04pm.